ANVISA registration 80020690418Valid until Sep 13, 2031ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV)
ANVISA Registration Number: 80020690418BIO-RAD LABORATORIOS BRASIL LTDABIO-RADRisk Class IV
Device names
- Technical name
- ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV)
- Risk class
- Class IV
PT: ANTÍGENO E ANTICORPO DO VÍRUS DA IMUNODEFICIÊNCIA HUMANA ADQUIRIDA TIPO 1, TIPO 2 E TIPO 1 SUBGRUPO O (HIV)
Registration details
- Registration Number
- 80020690418
- Process Number
- 25351490255202136
- CNPJ
- 03188198000177
Company information
- Registration Holder
- BIO-RAD LABORATORIOS BRASIL LTDA
- Manufacturer
- BIO-RAD
- Manufacturing Country
- France
PT: FRANÇA
Dates and status
- Publication Date
- Sep 13, 2021
- Validity
- 13/09/2031
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690418 and manufactured by BIO-RAD. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Sep 13, 2031.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.